|17.75||-0.14 / -0.78%|
Data as of 4:00pm ET
|17.75||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 17.00. The median estimate represents a +7.04% increase from the last price of 17.75.
The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.